Reducing Stroke Rates in Patients With Atrial Fibrillation

Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter

(2009) Stuart J. Connolly et al.   CIRCULATION

Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure

(2009) Barry M. Massie et al.   CIRCULATION

Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation

(2009) Stefan H. Hohnloser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical trials update from the American College of Cardiology 2008: Carisma, Trends, meta-analysis of Cox-2 studies, Hat, on-Target, Hyvet, Accomplish, Momentum, Protect, Horizon-hf and Reverse

(2008) John G.F. Cleland et al.   EUROPEAN JOURNAL OF HEART FAILURE

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

(2008)   LANCET

Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis

(2008) Henrik Sillesen et al.   STROKE